Jerald P. Radich, MD, of the University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses the management of chronic myeloid leukemia (CML) in resource-limited countries, including efforts from The Max Foundation, academia, as well as pharmaceutical and biotechnology companies to diagnose and treat patients with CML in developing countries. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).